banner

Investors

At ACADIA, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

06/15/20
- Submission based on positive results from the Phase 3 HARMONY study which showed a statistically significant 2.8 fold reduction in the risk of relapse of psychosis SAN DIEGO --(BUSINESS WIRE)--Jun. 15, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that the company submitted a
06/02/20
SAN DIEGO --(BUSINESS WIRE)--Jun. 2, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the Goldman Sachs 41 st Annual Global Healthcare Conference on Tuesday, June 9, 2020 , at 4:40 p.m. Eastern Time . The conference will be held virtually.
05/28/20
SAN DIEGO --(BUSINESS WIRE)--May 28, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today announced that Mark Schneyer has been appointed to the newly created position of Senior Vice President, Business Development and Chief Business Officer. Mr.